Hypera SA (HYPE3)

42.51
+0.90(+2.16%)
  • Volume:
    2,946,800
  • Bid/Ask:
    42.47/42.51
  • Day's Range:
    41.96 - 42.59

HYPE3 Overview

Prev. Close
41.61
Day's Range
41.96-42.59
Revenue
-
Open
42.01
52 wk Range
26.25-43.37
EPS
2.15
Volume
2,946,800
Market Cap
26.9B
Dividend (Yield)
1.5416
(3.63%)
Average Volume (3m)
3,561,742
P/E Ratio
16.69
Beta
0.515
1-Year Change
16.24%
Shares Outstanding
632,876,860
Next Earnings Date
27 Oct 2022
What is your sentiment on Hypera?
or
Market is currently closed. Voting is open during market hours.

Hypera SA Company Profile

Hypera SA Company Profile

Employees
9000
  • Type:Equity
  • Market:Brazil
  • ISIN:BRHYPEACNOR0

Hypera S.A. operates as a pharmaceutical company in Brazil. It offers prescription products under the Adacne, Addera, apri, AmpliumG, please, Celestamine, Celestone, Celestone Soluspan, Cizax, deciprax, Derive C Micro, Micro Drift, Dermotil Fusid, Digedrat, diprogent, Diprosalic, Diprosone, diprospan, Emprol XR, Flow, Garasone, Halobex, Lipanon, moon, Lydian, macrodantin, MaxSulid, milgamma, Mioflex – A, nesina, Novotram, oximax, peridal, Peridal Suspension, PredSim, pressaliv, Quadriderm, Rizi, Rizi M, softalm, tacroz, tinodin, umma, and velunid brands. The company also provides dermo-cosmetics products under the Mantecorp Skincare brands; and consumer health products under the Apracur, Benegrip, Coristina d, Engov, Epocler, Estomazil, and other brands. In addition, it offers nutritional and vitamin supplement products under the Tamarine, Vitasay, Biotônico Fontoura, and Zero-Cal brands; and similar and generic medicines under the Neo Química, Sodium Diclofenac, Hydroxyzine, Dipyron, Ibuprofen, Losartan Potassium, Mal Dexchlorpheniramine, Naproxene, Paracetamol, Simethicon, Loratadine, Omeprazole, Tadalaphyl, and Desogestrel brand names. The company was formerly known as Hypermarcas S.A. and changed its name to Hypera S.A. in February 2018. Hypera S.A. is based in São Paulo, Brazil.

Read More

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong BuyStrong BuyStrong BuyStrong BuyStrong Buy
Technical IndicatorsStrong BuyStrong BuyStrong BuyStrong BuyStrong Buy
SummaryStrong BuyStrong BuyStrong BuyStrong BuyStrong Buy